| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | JPS5850981B2 - | JP9113973 | 1973-08-13 | JPS5850981B2 | 1983-11-14 | ITO MASUMI; NOTANI JOJI |
| 122 | JPS5534132B2 - | JP12437177 | 1977-10-17 | JPS5534132B2 | 1980-09-04 | |
| 123 | Tricyclic compound and manufacture | JP2924678 | 1978-03-16 | JPS54125662A | 1979-09-29 | ONOKI KAZUHIRO; NAGAKURA MASAHIKO |
| 124 | Hydantoin derivative therapeutic medicine | JP14592678 | 1978-11-25 | JPS5495575A | 1979-07-28 | REINHAADO SAAJIESU |
| 125 | Hydantoin derivative therapeutic agent | JP14592578 | 1978-11-25 | JPS5495570A | 1979-07-28 | REINHAADO SAAJIESU |
| 126 | Spiroohydantoin | JP5706478 | 1978-05-13 | JPS53144575A | 1978-12-15 | REINBAADO SAAJIESU |
| 127 | JPS5035196A - | JP7694373 | 1973-07-07 | JPS5035196A | 1975-04-03 | |
| 128 | Photoelectric conversion element and imaging device | US12358335 | 2009-01-23 | US08053661B2 | 2011-11-08 | Tetsuro Mitsui; Kimiatsu Nomura; Tetsu Kitamura |
| A photoelectric conversion element is provided and includes: an electrically conductive thin layer; an organic photoelectric conversion layer containing a compound having a partial structure represented by the following formula (I) and a fullerene or a fullerene derivative; and a transparent electrically conductive thin layer. X represents O, S or N—R10, R10 represents a hydrogen atom or a substituent, Rx and Ry represent a hydrogen atom or a substituent, with at least one representing an electron-withdrawing group, Rx and Ry may combine to form a ring, R represents a bond (—), a hydrogen atom or a substituent, with at least one being the bond, nr represents an integer of 1 to 4, R's may be the same or different when nr is 2 or more, and R's at the 2- and 3-positions or R's at the 5- and 6-positions may combine with each other to form a ring. | ||||||
| 129 | Aminoamides as orexin antagonists | US12037975 | 2008-02-27 | US07829563B2 | 2010-11-09 | Luca Gobbi; Henner Knust; Parichehr Malherbe; Matthias Nettekoven; Emmanuel Pinard; Olivier Roche; Mark Rogers-Evans |
| The present invention relates to compounds of formula I wherein Ar1, Ar2, Ar3, n, and R1 to R8 are as defined herein and to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. These compounds are orexin receptor antagonists and may be useful in the treatment of disorders, in which orexin pathways are involved, like sleep disorders. | ||||||
| 130 | Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared | US11302810 | 2005-12-14 | US07737269B2 | 2010-06-15 | Helmut Reuscher; Mark Bauer |
| The invention relates to a process for the preparation of a cyclodextrin/alpha-lipoic acid complex, wherein in a first step, an alpha-lipoic acid and a cyclodextrin are dissolved in an aqueous alkaline solution having a pH above pH 7, and in a second step an acid is added to lower the pH of the solution to a pH below pH 7. | ||||||
| 131 | Photosensitive composition and acid generator | US10668348 | 2003-09-24 | US07033727B2 | 2006-04-25 | Kunihiko Kodama |
| A photosensitive composition of the present invention has excellent sensitivity and pattern profile, which comprises an acid generator having a specific structure. | ||||||
| 132 | β-thioamino acids | US10387843 | 2003-03-14 | US06846843B2 | 2005-01-25 | Boris Chizh; Matthias Gerlach; Michael Haurand; Claudia Puetz; Gero Gaube; D. Enders |
| Thio-alpha-amino acids of general formula (I), wherein R1, R2 and R3 have the meanings given in the description, methods for producing them, and medicaments containing these compounds. The invention also provides methods for treating pain and other diseases using the pharmaceutical compositions comprising the thioamino acids. | ||||||
| 133 | Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method | US10331785 | 2002-12-27 | US20030207201A1 | 2003-11-06 | Jun Hatakeyama; Tomohiro Kobayashi; Youchi Ohsawa |
| The invention provides a high-resolution resist material comprising an acid generator that has high sensitivity and high resolution with respect to high-energy rays of 300 nm or less, has small line-edge roughness, and is superior in heat stability and in shelf stability, and provides a pattern forming method that uses this resist material. The invention further provides a chemically amplified positive resist material comprising a base resin, an acid generator and a solvent in which the acid generator generates an alkylimidic acid containing a fluorine group, and provides a pattern forming method comprising a step of applying the resist material to the substrate, a step of performing exposure to a high-energy ray of a wavelength of 300 nm or less through a photomask following heat treatment, and a step of performing development by a developing solution following heat treatment. | ||||||
| 134 | Fluorescent stain containing pyrylium salt and fluorescent staining method of biological sample | US782798 | 1997-01-13 | US6022961A | 2000-02-08 | Nobuko Yamamoto; Tadashi Okamoto; Yoshinori Tomida; Takeshi Miyazaki; Masahiro Kawaguchi |
| A stain for a nucleic acid characterized by containing, as an effective component, a pyrylium salt compound having Y as a negative portion and a pyrylium ring or a pyrylium-similar ring, wherein the ring is comprised of X selected from O, S, Se and Te as a hetero atom and has substituents R.sup.1, R.sup.2 and R.sup.3, wherein each of R.sup.1 and R.sup.2 is independently a hydrogen atom, sulfonate group, amino group, substituted or unsubstituted aryl group, etc., R.sup.3 is -A or -L-A, L is -L.sup.1 -, -L.sup.2 -L.sup.3 - or -L.sup.4 -L.sup.5 -L.sup.6 -, and each of L.sup.1 to L.sup.6 is independently --(CH.dbd.CH)--, a divalent group derived from the substituted or unsubstituted aryl group, etc., A is a substituted or unsubstituted aryl group, etc., and Y.sup.- is an anion. A method for detecting a nucleic acid which comprises the steps of reacting a sample with the stain, and then detecting, by an optical means, the double-strand nucleic acid stained with the stain in the case that the double-strand nucleic acid is contained in the sample. | ||||||
| 135 | Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them | US990455 | 1997-12-15 | US5856338A | 1999-01-05 | Joachim Brendel; Hans Jochen Lang; Uwe Gerlach; Klaus Weidmann |
| Compounds of formula I ##STR1## having the meanings indicated in the claims are outstandingly active substances for the production of medicaments for the prophylaxis and therapy of cardiovascular disorders, in particular arrhythmias; for the treatment of ulcers of the gastrointestinal region; or for the treatment of diarrheal illnesses. | ||||||
| 136 | 2',3'-dideoxy-4'-thioribonucleosides and synthetic precursors thereof | US142907 | 1993-10-29 | US5478928A | 1995-12-26 | John A. Montgomery; John A. Secrist, III |
| 2',3'-dideoxy-4'-thioribonucleosides useful as antiviral agents in the treatment and prevention of AIDS are disclosed. In accordance with one aspect of the invention there are provided compounds of the formula ##STR1## where X.dbd.H, N.sub.3 or F, and B is a member selected from the group consisting of pyrimidine, 5-azapyrimidine, 6-azapyrimidine, 3-deazapyrimidine, purine, 3-deazapurine, 7-deazapurine, 8-azapurine, and 2-azapurine bases. The intermediate 1-O-acetyl-5-O-t-butyldiphenylsilyl-4-thio-2,3-dideoxyribofuranose is useful in the production of certain of the 2',3'-dideoxy-4'-thioribonucleosides. Other intermediates include the 4-thio-2,3-dideoxyribofuranose having different hydroxyl protecting groups and leaving groups. | ||||||
| 137 | Leukotriene antagonists | US37284 | 1987-04-10 | US4874777A | 1989-10-17 | F. Patrick Carr; Robert D. Dillard; Doris E. McCullough |
| This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes. | ||||||
| 138 | Oxime esters of substituted quinoline-8-carboxylic acids and use thereof as herbicides | US944519 | 1986-12-22 | US4808212A | 1989-02-28 | Peter Plath; Karl Eicken; Bernd Zeeh; Ulrich Eichenauer; Helmut Hagen; Rolf-Dieter Kohler; Norbert Meyer; Bruno Wuerzer |
| Oxime esters of substituted quinoline-8-carboxylic acids of the formula ##STR1## where X is hydrogen, C.sub.1 -C.sub.4 -alkyl or halogen, Z is hydrogen or methyl, R.sup.1 is C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.4 -alkoxymethyl, C.sub.1 -C.sub.4 -alkoxyethyl, C.sub.1 -C.sub.4 -alkylthiomethyl, C.sub.1 -C.sub.4 -alkylthioethyl, C.sub.1 -C.sub.4 -alkoxycarbonyl, C.sub.3 -C.sub.6 -alkenyl or C.sub.5 -C.sub.8 -cycloalkyl, each of which is unsubstituted or bears up to 3 methyl substituents, hydrogen, cyano, acetyl, benzoyl, unsubstituted benzyl or phenyl, or benzyl or phenyl bearing up to 3 substitutents selected from the group consisting of halogen, cyano, trifluoromethyl, C.sub.1 -C.sub.4 -haloalkyloxy, C.sub.1 -C.sub.6 -alkylthio, C.sub.1 -C.sub.4 -alkoxy, C.sub.1 -C.sub.4 -alkyl, hydroxy, dimethylamino or acetamino, R.sup.2 is hydrogen if R.sup.1 is not hydrogen, R.sup.2 further denotes C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.4 -alkoxymethyl, chloromethyl, azolylmethyl, 1,1-dimethoxymethyl, cyano, C.sub.1 -C.sub.4 -alkoxycarbony, C.sub.1 -C.sub.4 -alkoxy, phenyl if R.sup.1 is H, CH.sub.3 or acetyl, or R.sup.2 denotes, when R.sup.1 is H or methyl, furyl, tetrahydrofuryl, thienyl, tetrahydropyranyl, tetrahydrothiopyranyl, dihydro-.DELTA..sup.3 -pyranyl or dihydro-.DELTA..sup.3 -thiopyranyl; further, R.sup.1 and R.sup.2, together with the carbon atom to which they are linked, denote C.sub.1 -C.sub.12 -cycloalkylidene, C.sub.5 -C.sub.6 -cycloalkenylidene or 4-oxacyclohexadienylidene, each of which is unsubstituted or bears up to 3 methyl substituents, it being possible, where the ring is 5-membered or 6-membered, or doubly unsaturated 6-membered, for it to contain an oxygen or sulfur atom, their preparation, and their use as herbicides. | ||||||
| 139 | Circulation-active 1,4-dihydropyridine derivatives and use thereas | US890998 | 1986-07-25 | US4769375A | 1988-09-06 | Horst Meyer; Gerhard Franckowiak; Gunther Thomas; Matthias Schramm; Michael Kayser; Martin Bechem; Rainer Gross |
| Circulation-active dihydropyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl or heterocyclic,R.sup.2 is H, NO.sub.2, CN, C.sub.1 -C.sub.8 -alkylsulphonyl, aryl or carboalkoxy,R.sup.3 is alkyl or aryl,R.sup.4 is H or alkyl,X is C.dbd.O or a direct bond, andn is a number from 1 to 20,or physiologically acceptable salts thereof. A synthesis using morpholines or thiomorpholines is also disclosed. | ||||||
| 140 | Cyclohexenone derivatives, the preparation and use thereof as herbicides and plant growth regulators | US3148 | 1987-01-14 | US4761486A | 1988-08-02 | Bernd Zeeh; Dieter Jahn; Michael Keil; Dieter Kolassa; Bruno Wuerzer; Norbert Meyer; Wilhelm Rademacher; Johann Jung |
| Cyclohexenone derivatives of the formula ##STR1## where R.sup.1, R.sup.2, A and X have the meanings given in the disclosure, a process for their manufacture, herbicidal and plant growth-regulating agents containing the novel active ingredients, and methods of combating unwanted plant growth and of regulating plant growth. | ||||||
QQ群二维码
意见反馈
意见反馈